SELLAS Life Sciences Group, Inc. — Director's Dealing 2014

Apr 21, 2014

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Galena Biopharma, Inc. (GALE)
CIK: 0001390478
Period of Report: 2014-04-18

Reporting Person: Einhorn Irving M. (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-04-18	Stock Option (right to buy)	$1.8	A	100000	Acquired	2024-04-18	Common Stock (100000)	Direct

Footnotes

F1: The option will vest in equal quarterly installments of 25,000 shares on each of July 18, 2014, October 18, 2014, January 18, 2015 and April 18, 2015.

F2: The option will terminate immediately in the event the reporting person is terminated for cause prior to the expiration date.